I trained in Respiratory and General Internal Medicine in North-West London, during which time I completed a PhD in the immunology of tuberculosis with Profs Ajit Lalvani and Onn Min Kon at St. Mary's Hospital. I started working as a consultant physician in Respiratory and Acute Internal Medicine at NHS Tayside in 2017.

My main clinical interests incorporate complex lung infections, particularly tuberculosis, chronic pulmonary aspergillosis, and non-tuberculous mycobacteria: I convene NHS Tayside's Complex Pumonary Infection MDT. I also work in Medical High Dependency Unit (MHDU) at Ninewells Hospital, and have interests in the delivery of care in both chronic and acute respiratory infections, including Influenza, and more recently COVID-19. As part of this, I was the Lead for Winter Planning at NHS Tayside during thre pandemic in 2020-21.

I have been member of the Working Groups on the British Thoracic Society Clinical Statments on Ocular Tuberculosis, and Fungal Lung Diseases.

I am currently the Co-Chair of the Scottish Health Protection Tuberculosis Network, and a Clinical Service Advisor to the UK MDR-TB Clinical Advisory Service. I was Chair of the Pulmonary Infection Special Advisory Group in the British Thoracic Society 2019-2023, and was a co-opted member of the UK New and Emerging Respiratory Virus Threats Advisory Group (NERVTAG) during the first year of the COVID-19 pandemic.

I teach 1st year MB ChB Respiratory SIP Modules on Tuberculosis and Respiratory Infections.

In 2019 I was awarded a Chief Scientist's Office NRS Career Fellowship to study fungal lung infections, and am a Principal Investigator on the MRC-funded Fungal Resistance Evolution and Acquisition in chronic Lung disease (FREAL) study, with Dr. Anand Shah at Imperial College London, and Prof. James Chalmers at the University of Dundee.

During the COVID-19 pandemic, I was awarded a CSO grant as Chief Investigator for the FOcused LongitudinaL Observational Study to Improve KnoWledge of COVID-19 (FOLLOW-COVID), which led to novel insights into epithelial and ciliary biology following SARS-CoV2 infection, with Professor Amelia Shoemark. I was a local PI on the UK wide PHOSP-COVID trial which also looked at outcomes following COVID-19 Infection. I was also a co-investigator on the PREDICT-COVID and STOP-COVID studies, and a local PI on the ATOMIC2 trial of Azithromycin in early disease.

I am now a Tayside Medical Science Centre (TASC) Research Fellow and am a PI for the ENCORE study into Nebulised Liposomal Amikacin in MAC-PD, a PI for the CAPSULE study in QoL in Chronic Pulmonary Aspergillosis, and a PI for the TB-DILI study. I provide research bronchoscopy support and site of disease sampling for the BRILLIANT study with Prof. James Chalmers.